North America Dialysis Market Analysis Report 2022 to 2030

North America Dialysis Market Analysis

$ 3999

This report presents a strategic analysis of the North America Dialysis Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the North America Dialysis Market, offering unmatched value, accuracy and expert insights.

ID: IN10NAPH010 CATEGORY: Pharmaceuticals GEOGRAPHY: North America

Buy Now

North America Dialysis Market Executive Summary

North America's fastest-growing economy in 2021 was the United States. United States health spending is projected to have grown by 4.2% to $4.3 trillion in 2021, compared with a growth surge of 9.7% in 2020, according to the report from actuaries at the Centers for Medicare and Medicaid Services.

Total health spending in Canada reached a new level in 2021, at more than $308 billion, or $8,019 per Canadian. Health expenditure represented around 12.7% of Canada’s gross domestic product (GDP) in 2021, following a high of 13.7% in 2020. Governments and insurance stakeholders also need to discuss win-win reimbursement schemes that allow the democratization of telemedicine and provide lasting benefits for patients at an effective cost.

The pharmaceutical industry covers all aspects of medication research, development, production, and distribution. Pharma revenues worldwide reached $1.42 trillion in 2021 due to the market's rapid growth over the previous two decades. With the introduction of new technology as well as more economical and effective manufacturing techniques, the industry has experienced a significant transition. Additionally, the market growth has been positively driven by rising investment flow in this sector.

Dialysis is a procedure used to remove waste materials like urea and creatinine from the blood as a result of inadequate kidney function; it is typically necessary for persons with chronic renal failure. The process is crucial for a kidney transplant and end-stage renal disease (ESRD) treatment. The electrolyte balance is restored, the blood is cleansed, and extra fluid and toxins are taken out during this operation. Hemodialysis and peritoneal dialysis are the two methods used to do dialysis. Waste materials like urea are eliminated extracorporeal from the patient's blood during hemodialysis. The peritoneum in the abdomen is utilized for dialysis in peritoneal dialysis.

Market Size and Key Findings

The size of the global dialysis market, estimated at USD 105.58 billion in 2021, is expected to grow to USD 145.85 billion by 2030, with a CAGR of 3.6% from 2022 to 2030.

North America Dialysis Market Size (In $Bn) (2021-2030F)

Market Dynamics

Market Growth Drivers & Restraints Analysis

Chronic kidney disease affects 10% of the world's population, and it causes more than a million deaths annually because there are no effective treatments available. As a result, the use of dialysis has spread more widely throughout time, contributing to the expansion of the worldwide dialysis market.

A growing number of patients with end-stage renal disease (ESRD) and more financing for better dialysis services and products also contribute to the market's expansion. Throughout the projection period, the size of the dialysis market is projected to see positive effects due to the rising prevalence of diabetes, which at first impairs kidney function.

However, the risks and side effects of dialysis as well as product recalls may restrain the market's expansion. Furthermore, the future will provide new chances for the expansion of the worldwide dialysis market due to the rise in renal failure cases, a dearth of kidney donors for transplants, the time-consuming nature of kidney transplant operations, and the rising demand for home peritoneal dialysis.

Competitive Landscape

Key Players

The prominent players operating in this market include Fresenius Se And Co. Kgaa, Asahi Kasei Corporation, B. Braun Melsungen Ag, Baxter International Inc., Becton, Dickinson, and Company (C. R. Bard, Inc.), Davita, Angiodynamics Inc., Diaverum Deutschland Gmbh., Nikkiso Co. Ltd., Nipro Corporation

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Dialysis Market Segmentation

The Dialysis Market is segmented as mentioned below:

By Type (Revenue, USD Billion):

Hemodialysis (HD)
- Conventional Hemodialysis
- Short daily hemodialysis
- Nocturnal hemodialysis
Peritoneal dialysis (PD)
- Continuous Ambulatory Peritoneal Dialysis (CAPD)
- Automated Peritoneal Dialysis (APD)

By Product & Services (Revenue, USD Billion):

Equipment
- Dialysis Machines
- Water Treatment Systems
- Others Dialysis Equipment
Consumables
- Dialyzers
- Catheters
- Other Dialysis Consumables
Dialysis Drugs
Services

By End User (Revenue, USD Billion):

In-center dialysis
Home dialysis

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.